Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lung Neoplasms × Exercise × 30 days × Clear all

Sponsor

Conditions

Motor Activity 7 Breast Neoplasms 3 Obesity 2 Neoplasms 2 Sarcopenia 1 Prostatic Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Peripheral Nervous System Diseases 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Neurotoxicity Syndromes 1 Multiple Endocrine Neoplasia Type 1 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Follicular 1 Lymphedema 1 Hodgkin Disease 1 Hematologic Neoplasms 1 Endometrial Neoplasms 1 Dementia 1 Colonic Neoplasms 1 Cognitive Dysfunction 1 Brain Neoplasms 1 Anomia 1 Alzheimer Disease 1

Interventions

pembrolizumab 33 Carboplatin 32 Specimen Handling 28 Pemetrexed 28 Cisplatin 25 Magnetic Resonance Spectroscopy 21 durvalumab 17 Paclitaxel 15 Gemcitabine 14 Immunoglobulin G 12 atezolizumab 11 Nivolumab 11 Disulfides 11 Radiosurgery 10 Biopsy 9 130-nm albumin-bound paclitaxel 9 osimertinib 8 Radiotherapy 8 Platinum 8 Cetuximab 8 1,2-diaminocyclohexaneplatinum II citrate 7 Bevacizumab 6 X-Rays 5 Taxes 5 Standard of Care 5 Radiation 5 Etoposide 5 Docetaxel 5 Surgical Procedures, Operative 4 Practice Guidelines as Topic 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡